Camber Spine to Roll Out Education Initiatives and Expand Product Portfolio in 2022

Camber Spine, a leading innovator in spine and medical technologies has announced a robust calendar of clinical education and product portfolio expansions in 2022.

Camber Spine notes plans for the year include four spine surgical training labs focused on the Oblique Lateral Interbody Fusion Surgery (OLIF) technique. The labs, part of the Camber Education Program, are designed to give surgeons an opportunity to further their experience accessing the anterior spine (L2-S1) through an oblique approach. The program faculty will use didactic sessions, hands-on cadaveric training and case review to provide a full-day session to benefit surgeon attendees. Additional training labs on will be offered throughout the year on ALIF, LLIF, PLIF and TLIF techniques.

Camber Spine will also be offering unique OLIF training opportunities via its one-on-one Clinical Preceptor Training program with Dr. John I. Williams, Spine Surgeon, ORTHO Northeast, Fort Wayne, IN.

In addition, Camber’s product pipeline is scheduled to produce a number of key product launches throughout 2022, starting with innovative navigation and MIS instruments to be announced later in Q1 and products to compliment a complete posterior approach, also in Q1. Camber will also continue to expand its award-winning Spira and Enza technology platforms in the first three quarters of this year, with a series of product launches, including a full compliment of biologic options.

Camber Spine will be exhibiting and presenting its products (including SPIRA-T, SPIRA-P and ORTHROS) at a number of clinical conferences throughout the year, including AANS/CNS in February, AAOS in March, IMAST and AANS in April, ISASS in June, and other events, including NASS in October, where Camber will be hosting multiple clinical presentations.

“We now offer interbody options for anterior column reconstruction from every possible angle,” said Seth Anderson, Camber’s Chief Innovation Officer. “To support this, education and innovation continue to be our top priorities. Our patented and award-winning technology platforms will be expanding significantly this year, so hosting a broad selection of presentation and training opportunities with thought leaders is timely. This is likely to be our most productive year to date in terms of product launches and hands-on training.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version